For example, MEDAG is involved in the signal pathway of “type 2 diabetes mellitus” and “mature onset diabetes of the young.” In “type 2 diabetes mellitus,” the expression levels of INS and GCK were significantly downregulated. Here, INS is linked to type 2 diabetes mellitus.